Microbiological assessment of the colonization of a central venous catheter insertion site considering two transparent dressings
DOI:
https://doi.org/10.11606/issn.2176-7262.v53i2p135-145Keywords:
Central Venous Catheters, Dressing, Occlusive Dressings, MicrobiologyAbstract
Study design: a prospective, cross-sectional study. Objectives: identify microbiological growth at the insertion site of the central venous catheter covered by a chlorhexidine impregnated dressing or a transparent polyurethane dressing, and identify antimicrobial sensitivity. Methods: immediately after dressing removal, a skin swab was collected from the catheter insertion site and seeded in blood agar plates and MacConkey agar, then incubated in bacteriological incubators at 35 °C. After 24 hours, the plates were analyzed to verify the presence of microbial growth. In the samples that displayed microbial growth, the identification and the sensitivity test were performed using the automated equipment Vitek II (Biomerieux®). Results: A total of 45 patients were treated with chlorhexidine impregnated dressing and 47 with transparent polyurethane dressing. In the chlorhexidine dressing group, 13 swabs samples presented with microbial growth of the following bacterial populations: Acinetobacter baumannii, Pseudomonas aeruginosa, Morganella morganii, Enterobacter cloacae, Staphylococcus aureus, and Staphylococcus epidermidis. Staphylococcus aureus presented resistance to oxacillin. In the transparent polyurethane dressing group, six samples were positive for the growth of Serratia marcescens, Acinetobacter baumannii, Staphylococcus epidermidis, Staphylococcus haemolyticus, and amikacin resistant Klebsiella pneumoniae (Klebsiella pneumoniae carbapenemase - KPC). Conclusion: The results demonstrate higher bacterial growth in the chlorhexidine impregnated dressing compared to the transparent polyurethane dressing.
Downloads
References
Centers for Diseases Control and Prevention (CDC). Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection) [Internet]. Atlanta: Centers for Diseases Control and Prevention; 2020 [updated 2020 Jan]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39(4 Suppl 1):S1-34. https://doi.org/10.1093/cid/cir257
Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Withdrawn: gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2016; (5):CD003827. https://doi.org/10.1002/14651858.CD003827
Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, et al. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev 2015; (9):CD010367. https://doi.org/10.1002/14651858.CD010367.pub2
Bashir MH, Olson LK, Walters SA. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. Am J Infect Control 2012;40(4):344-8. https://doi.org/10.1016/j.ajic.2011.03.030
Jeanes A, Bitmead J. Reducing bloodstream infection with a chlorhexidine gel IV dressing. Br J Nurs 2015; 24(19): S14-9. https://doi.org/10.12968/bjon.2015.24.Sup19.S14
Safdar N, O'Horo JC, Ghufran A, Bearden A, Didier ME, Chateau D, et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis. Crit Care Med 2014; 42(7):1703-13. https://doi.org/10.1097/CCM.0000000000000319
Margatho AS, Ciol MA, Hoffman JM, Reis PED, Furuya RK, Lima DAFS, et al. Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: A pilot randomised controlled trial. Aust Crit Care 2019;471-478. https://doi.org/10.1016/j.aucc.2018.11.001
Kawamura H, Takahashi N, Takahashi M, Taketomi A. Differences in microorganism growth on various dressings used to cover injection sites: inspection of the risk of catheter-related bloodstream infections caused by Gram-negative bacilli. Surg Today 2014; 44(12):2339-44. https://doi.org/10.1007/s00595-014-0935-z
Choudhury MA, Sidjabat HE, Rathnayake IU, Gavin N, Chan RJ, Marsh N, et al. Culture-independent detection of chlorhexidine resistance genes qacA/B and smr in bacterial DNA recovered from body sites treated with chlorhexidine-containing dressings. J Med Microbiol 2017; 66(4):447-53. https://doi.org/10.1099/jmm.0.000463
Carty N, Wibaux A, Ward C, Paulson DS, Johnson P. Antimicrobial activity of a novel adhesive containing chlorhexidine gluconate (CHG) against the resident microflora in human volunteers. J Antimicrob Chemother 2014; 69(8):2224-9. https://doi.org/10.1093/jac/dku096
Carrer S, Bocchi A, Bortolotti M, Braga N, Gilli G, Candini M, et al. Effect of different sterile barrier precautions and central venous catheter dressing on the skin colonization around the insertion site. Minerva Anestesiol 2005;71(5):197-206. https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2005N05A0197
Gerçeker GÖ, Yardımcı F, Aydınok Y. Randomized controlled trial of care bundles with chlorhexidine dressing and advanced dressings to prevent catheter-related bloodstream infections in pediatric hematology-oncology patients. Eur J Oncol Nurs 2017; 28:14-20. https://doi.org/10.1016/j.ejon.2017.02.008
Biehl LM, Huth A, Panse J, Kramer C, Hentrich M, Engelhardt M, et al. A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 2016;27(10):1916–22. https://doi.org/10.1093/annonc/mdw275
Düzkaya DS, Sahiner NC, Uysal G, Yakut T, Çitak A. Chlorhexidine-impregnated dressings and prevention of catheter-associated blood- stream infections in a pediatric intensive care unit. Crit Care Nurse 2016;36(6): e1-e7. https://doi.org/10.4037/ccn2016561
Wang HX, Xie SY, Wang H, Chu HK. The effects of chlorhexidine dressing on health care-associated infection in hospitalized patients: a meta-analysis. Iran J Public Health 2019; 48(5):796-807. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717407/
Eggimann P, Pagani JL, Dupuis-Lozeron E, Ms BE, Thévenin MJ, Joseph C, et al. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years. Intensive Care Med 2019;45(6):823-33. https://doi.org/10.1007/s00134-019-05617-x
Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. Jama 2009;301(12):1231–41.https://doi.org/10.1001/jama.2009.376
Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012;186(12):1272–8. https://doi.org/10.1164/rccm.201206-1038OC
Wei L, Li Y, Li X, Bian L, Wen Z, Li M. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter related complications: a systematic review and meta-analysis. BMC Infect Dis 2019;19(1):429. https://doi.org/10.1186/s12879-019-4029-9
Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35(Suppl 2):S89-107.
Koljalg S, Naaber P, Mikelsaar M. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J Hosp Infect 2002; 51(2):106-13. https://doi.org/10.1053/jhin.2002.1204
Lima MFP, Borges MA, Parente RS, Victória Júnior RC, Oliveira ME. Staphylococcus aureus e as infecções hospitalares – revisão de literatura. UNINGÁ Rev 2015;21(1):32-9. http://revista.uninga.br/index.php/uningareviews/article/view/1616>.
Downloads
Published
Issue
Section
License
